Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II

PHASE4CompletedINTERVENTIONAL
Enrollment

457

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Cerebral InfarctionAtherosclerosis
Interventions
DRUG

clopidogrel

Clopidogrel 75mg once a day plus placebo of cilostazol twice a day

DRUG

Cilostazol

Cilostazol 100mg twice a day plus placebo of clopidogrel once a day

Trial Locations (19)

Unknown

Prince of Wales Hospital, Hong Kong

Queen Mary Hospital, Hong Kong

Philippine General Hospital, Manila

University of Santo Tomas Hospital, Manila

Seoul National University Bundang Hospital, Seongnam

Ramathibodi Hospital, Bangkok

Siriraj Hospital, Bangkok

143-729

Konkuk Univ. Hospital, Seoul

411-706

Inje University Ilsan Paik Hospital, Goyang-si

410-773

Dongguk University International Hospital, Goyang

430-070

Hallym University Sacred Heart Hospital, Anyang

140-743

Soonchunhyang University Hospital, Seoul

400-103

Inha University Hospital, Inchon

110-744

Seoul National University Hospital, Seoul

134-701

Kangdong Sacred Heart Hospital, Hallym University, Seoul

135-710

Samsung Medical Center, Seoul

138-736

Asan Medical Center, Seoul

156-707

Seoul National University Boramae Hospital, Seoul

280-1

Eulji Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Korea Otsuka International Asia Arab

INDUSTRY

lead

Asan Medical Center

OTHER

NCT00130039 - Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II | Biotech Hunter | Biotech Hunter